Companion Diagnostics Deals and Alliances of 2017
ResearchMoz presents professional and in-depth study of "Companion Diagnostics Deals and Alliances of 2014".
The Companion Diagnostics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.
Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.
The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.
Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.
Chapter 2 provides a comprehensive listing of leading deals by deal values, most active dealmakers, big pharma and big biotech deal activity.
Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by big pharma company profiles, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a comprehensive listing of leading deals of 2014 listed by big biotech company profiles, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 5 provides a comprehensive directory of all partnering deals announced during 2014.
The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=256059
Table of Content
Executive Summary
Introduction
Chapter 1 – Trends in dealmaking during 2014
1.1 Introduction
1.2. Partnering by deal type
1.3. Partnering by industry sector
1.4. Partnering by stage of development
1.5. Partnering by technology type
1.6. Partnering by therapy area
Chapter 2 – Leading deals during 2014
2.1. Introduction
2.2 Most active partnering in 2014
2.3. Top deals by value during 2014
2.4. Big pharma dealmaking activity
2.5. Big biotech dealmaking activity
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=256059
Chapter 3 – Big pharma deals during 2014
3.1. Introduction
3.2. How to use big pharma partnering deals
3.3. Big pharmapartnering company profiles
Chapter 4 – Big biotech deals during 2014
4.1. Introduction
4.2. How to use big biotech partnering deals
4.3. Big biotech partnering company profiles
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://latestmedicalrelatedresearchreport.blogspot.in/
The Companion Diagnostics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.
Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.
The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.
Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.
Chapter 2 provides a comprehensive listing of leading deals by deal values, most active dealmakers, big pharma and big biotech deal activity.
Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by big pharma company profiles, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a comprehensive listing of leading deals of 2014 listed by big biotech company profiles, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 5 provides a comprehensive directory of all partnering deals announced during 2014.
The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=256059
Table of Content
Executive Summary
Introduction
Chapter 1 – Trends in dealmaking during 2014
1.1 Introduction
1.2. Partnering by deal type
1.3. Partnering by industry sector
1.4. Partnering by stage of development
1.5. Partnering by technology type
1.6. Partnering by therapy area
Chapter 2 – Leading deals during 2014
2.1. Introduction
2.2 Most active partnering in 2014
2.3. Top deals by value during 2014
2.4. Big pharma dealmaking activity
2.5. Big biotech dealmaking activity
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=256059
Chapter 3 – Big pharma deals during 2014
3.1. Introduction
3.2. How to use big pharma partnering deals
3.3. Big pharmapartnering company profiles
Chapter 4 – Big biotech deals during 2014
4.1. Introduction
4.2. How to use big biotech partnering deals
4.3. Big biotech partnering company profiles
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://latestmedicalrelatedresearchreport.blogspot.in/
Comments
Post a Comment